Diversity-oriented asymmetric synthesis of hapalosin: Construction of three small C9/C4/C3-modified hapalosin analogue libraries

Journal of Combinatorial Chemistry

Volumn 9, Issue 3, 2007, Pages 386-394

  Dai, Chao Feng ^a   Cheng, Fang ^a   Xu, Hai Chao ^a   Ruan, Yuan Ping ^a   Huang, Pei Qiang ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEPSIPEPTIDE; HAPALOSIN; LACTAM; LACTONE; PEPTIDE LIBRARY;

ARTICLE; CHEMISTRY; CONFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; SYNTHESIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPSIPEPTIDES; LACTAMS; LACTONES; MOLECULAR CONFORMATION; PEPTIDE LIBRARY; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM;

EID: 34249931968     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc060166h     Document Type: Article

References (122)

1. (a) Fojo, A. T. Cancer Treat Res. 1989, 48, 27.
2. (b) Deuchars, K. L.; Ling, V. Semin. Oncol. 1989, 16, 156.
3. (c) Raderer, M.; Scheithauer, W. Cancer 1993, 72, 3553.
4. (d) Simon, S. M.; Schindler, M. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3497.
5. (e) Sikic, B. I. Fisher, G. A.; Lum, B. L.; Halsey, J.; Beketic-Oreskovic, L. Chen, G. Cancer Chemother. Pharmacol. 1997, 40 (Suppl), S13-9.
6. (f) Lehne, G. Curr. Drug Targets 2000, 1, 85.
7. Startmann, K.; Burgoyne, D. L.; Moore, R. E.; Patterson, G. M. L. J. Org. Chem. 1994, 59, 7219.
8. For a review on the synthesis of hapalosin, see: Nishiyama, S. J. Syn. Org. Chem. Jpn. 2001, 59, 938.
9. For syntheses of hapalosin, see: (a) Dinh, T. Q.; Armstrong, R. W. J. Org. Chem. 1995, 60, 8118.
10. (b) Ghosh, A. K.; Liu, W.; Xu, Y.; Chen, Z. Angew. Chem., Int. Ed. Engl. 1996, 35, 74.
11. (c) Ohmori, K.; Okuno, T.; Nishiyama, S.; Yamamura, S. Tetrahedron Lett. 1996, 37, 3467.
12. (d) Dinh, T. Q.; Du, X.; Armstrong, R. W. J. Org. Chem. 1996, 61, 6606.
13. (e) Wagner, B.; Beugelmans, R.; Zhu, J. Tetrahedron Lett. 1996, 37, 6557.
14. (f) Okuno, T.; Ohmori, K.; Nishiyama, S.; Yamamura, S.; Nakamura, K.; Houk, K. N.; Okamoto, K. Tetrahedron 1996, 52, 14723.
15. (g) Wagner, B.; Gonzalez, G. I.; Dau, M. E. T. H.; Zhu, J. Bioorg. Med. Chem. 1999, 7, 737.
16. (h) Haddad, M.; Botuha, C.; Larchevêque, M. Synlett 1999, 1118.
17. (i) O'Connell, C. E.; Salvato, K. A.; Meng, Z.; Littlefield, B. A.; Schwartz, C. E. Bioorg. Med. Chem. Lett. 1999, 9, 1541.
18. (j) Hermann, C.; Pais, G. C. G.; Geyer, A.; Kuhnert, S. M.; Maier, M. E. Tetrahedron 2000, 56, 8461.
19. (k) Oshitari, T.; Saiyinbilige; Mandai, T. Heterocycles 2004, 62, 185.
20. (l) Palomo, C.; Oiarbide, M.; Garcia, J. M.; Gonzalez, A.; Pazos, R.; Odriozola, J. M.; Banuelos, P.; Tello, M.; Linden, A. J. Org. Chem. 2004, 69, 4126.
21. (a) Dinh, T. Q.; Smith, C. D.; Armstrong, R. W. J. Org. Chem. 1997, 62, 790.
22. (b) Dinh, T. Q.; Du, X.; Smith, C. D.; Armstrong, R. W. J. Org. Chem. 1997, 62, 6773.
23. (c) Kashihara, N.; To-e, S.; Nakamura, K.; Umezawa, K.; Yamamura, S.; Nishiyama, S. Bioorg. Med. Chem. Lett. 2000, 10, 101.
24. (d) Hermann, C.; Giammasi, C.; Geyer, A.; Maier, M. E. Tetrahedron 2001, 57, 8999.
25. (e) For the synthesis of hapalosin mimetics, see: Dinh, T. Q.; Smith, C. D.; Du, X. H.; Armstrong, R. W. J. Med. Chem. 1998, 41, 981.
26. (f) Olsen, J. A.; Jensen, K. J.; Nielsen, J. J. Comb. Chem. 2000, 2, 143.
27. 4i (showed only a slight loss in the MDR-reversing activities).
28. For the asymmetric synthesis of NMAHPPA, see: (a) Reddy, G. V.; Rao, G. V.; Iyengar, D. S. Chem. Commun. 1999, 317.
29. (b) Pais, G. C. G.; Maier, M. E. J. Org. Chem. 1999, 64, 4551.
30. (c) Reddy, G. V.; Rao, G. V.; Iyengar, D. S. Chem. Lett. 1999, 703.
31. (d) Catasús, M.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron Lett. 1999, 40, 9309.
32. (e) Maier, M. E.; Hermann, C. Tetrahedron 2000, 56, 557.
33. (f) Mula, S.; Chattopadhyay, S. Lett. Org. Chem. 2006, 3, 54.
34. (g) For the syntheses of non-N-Me analog of NMAHPPA, namely, (3S,4R)-AHPPA, see: Rich, D. H.; Sun, E. T. O. J. Med. Chem. 1980, 23, 27.
35. (h) Maibaum, J.; Rieh, D. H. J. Org. Chem. 1988, 53, 869.
36. (i) Nishi, T.; Kitamura, M.; Ohkuma, T.; Noyori, R. Tetrahedron Lett. 1988, 29, 6327.
37. (j) Raddata, P.; Radunz, H.-E.; Schneider, G.; Schwartz, H. Angew. Chem., Int. Ed. Engl. 1988, 27, 426.
38. (k) Parkes, K. E. B.; Bushnell, D. J.; Crackett, P. H.; Dunsdon, S. J.; Freeman, A. C.; Gunn, M. P.; Hopkins, R. A.; Lambert, R. W.; Martin, J. A.; Merrett, J. H.; Redshaw, S.; Spurden, W. C.; Thomas, G. J. J. Org. Chem. 1994, 59, 3656.
39. (l) Doi, T.; Kokubo, M.; Yamamoto, K.; Takahashi, T. J. Org. Chem. 1998, 63, 428.
40. For recent reviews on the asymmetric aldol reaction, see: (a) Modern Aldol Reactions; Mahrwald, R., Ed; Wiley-VCH: Weimhein, Germany, 2004.
41. (b) Palomo, C.; Oiarbide, M.; Garcia, J. M. Chem. Soc. Rev. 2004, 33, 65.
42. (c) Palomo, C.; Oiarbide, M.; Garcia, J. M. Chem. - Eur. J. 2002, 8, 37.
43. Combinatorial Chemistry; Fenniri, H., Ed.; University Press: Oxford, U.K., 1998.
44. (a) Devlin, J. P. High Throughput Screening: The Discovery of Bioactive Substances; Dekker: New York, 1997.
45. (b) Kahn, M. High Throughput Screening for Novel Anti-inflammatories; Birkhauser: Basel, Swtizerland, 2000.
46. (a) Bunin, B. A.; Ellman, J. A. J. Am. Chem. Soc. 1992, 114, 10997.
47. (b) Bunin, B. A.; Plunkett, M. J.; Ellman, J. A. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 4708.
48. (c) Buskirk, A. R.; Liu, D. R. Chem. Biol. 2004, 12, 151.
49. (d) Arkin, M. Curr. Opin. Chem. Biol. 2005, 9, 317.
50. ( 12) (a) Storer, R. Drug Discovery Today 1996, 1, 248.
51. (b) Curran, D. P. Chemtracts: Org. Chem. 1996, 9, 75.
52. (c) Boger, D. L.; Chai, W. y.; Jin, Q. J. Am. Chem. Soc. 1998, 120, 7220.
53. (d) An, H.; Cook, P. D. Chem. Rev. 2000, 100, 3311.
54. (e) Baldino, C. M. J. Comb. Chem. 2000, 2, 89.
55. (f) Sauvagnat, B.; Kulig, K.; Lamaty, F.; Lazaro, R.; Martinez, J. J. Comb. Chem. 2000, 2, 134.
56. (g) Organ, M. G.; Arvanitis, E. A.; Dixon, C. E.; Lavorato, D. J. J. Comb. Chem. 2001, 3, 473.
57. (h) Liang, X.; Bols, M. J. Chem. Soc., Perkin Trans. 1 2002, 503.
58. (i) Mukade, T.; Dragoli, D. R.; Ellman, J. A. J. Comb. Chem. 2003, 5, 590.
59. For reviews on diversity-oriented organic synthesis, see: (a) Schreiber, S. L. Science 2000, 287, 1964.
60. (b) Arya, P.; Chou, D. T. H.; Baek, M. G. Angew. Chem., Int. Ed. 2001, 40, 339.
61. (c) Spring, D. R. Org. Biomol. Chem. 2003, 1, 3867.
62. (d) Chem. Biol. 2002, 9, 1.
63. (e) Shang, S.; Tan, D. S. Curr. Opin. Chem. Biol. 2005, 9, 248.
64. (g) For the extension of the concept of DOS, see: Schlosser, M. Eur. J. Org. Chem. 2001, 3975.
65. (h) Marzi, E.; Schlosser, M. Tetrahedron 2005, 61, 3393.
66. (i) ref 17a.
67. For selective examples, see: (a) Cossy, J.; Rasamison, C.; Pardo, D. G. J. Org. Chem. 2001, 66, 7195.
68. (b) Youngman, M. A.; Dax, S. L. J. Comb. Chem. 2001, 3, 469.
69. (c) Jang, W. B.; Hu, H.; Lieberman, M. M.; Morgan, J. A.; Stergiades, I. A.; Clark, D. S.; Tius, M. A. J. Comb. Chem. 2001, 3, 346.
70. (d) Micalizio, G. C.; Schreiber, S. L. Angew. Chem., Int. Ed. 2002, 41, 152.
71. (e) Walters, M. A.; La, F.; Deshmukh, P.; Omecinsky, D. O. J. Comb. Chem. 2002, 4, 125.
72. (f) Gardiner, J. M.; Crewe, P. D.; Smith, G. E.; Veal, K. T. Chem. Commun. 2003, 618.
73. (g) Chen, C.; Li, X. D.; Schreiber, S. L. J. Am. Chem. Soc. 2003, 125, 10174.
74. (h) Spino, C.; Gund, V. G.; Nadeau, C. J. Comb. Chem. 2005, 7, 345.
75. Keni, M.; Tepe, J. J. J. Org. Chem. 2005, 70, 4211.
76. (i) Masse, C. E.; Ng, P. Y.; Fukase, Y.; Sanchez-Rosello, M.; Shaw, J. T. J. Comb. Chem. 2006, 8, 293.
77. For the use of Grignard reagents in diversity-oriented organic synthesis, see: (a) Fakhfakh, M. A.; Franck, X.; Fournet, A.; Hocquemiller, R.; Figadère, B. Tetrahedron Lett. 2001, 42, 3847.
78. (b) Francek, X.; Hocquemiller, R.; Figadère, B. Chem. Commun. 2002, 160.
79. (c) Liang, X.; Bols, M. J. Chem. Soc., Perkin Trans. 1 2002, 503.
80. (d) Baruah, M.; Bols, M. J. Chem. Soc., Perkin Trans. 1 2002, 509.
81. (e) Bulow, A.; Sinning, S.; Wiborg, O.; Bols, M. J. Comb. Chem. 2004, 6, 509.
82. (f) For a review on the use of Grignard reagents in solid-phase organic synthesis, see: Franzén, R. G. Tetrahedron 2000, 56, 685.
83. For discussions on the importance and challenge in constructing library of macrocycles and some new methodologies for the efficient synthesis of macrocycles, see: (a) Jensen, K. J.; Alsina, J.; Songster, M. F.; Vágener, J.; Albericio, F.; Barany, G. J. Am. Chem. Soc. 1998, 120, 5441.
84. (b) Cristau, P.; Vors, J.-P.; Zhu, J. Org. Lett. 2001, 3, 4079.
85. (c) Bughin, C.; Zhao, G.; Bienaymé, H.; Zhu, J. Chem. - Eur J. 2006, 72, 1174.
86. For a report on the synthesis of macrocyclic natural productlike libraries, see: (a) Borman, S. Chem. Eng. News 2003, 81 (43), 45.
87. (b) For selected examples, see: Nicolaou, K. C.; Pastor, J.; Winssinger, N.; Murphy, F. J. Am. Chem. Soc. 1998, 120, 5132.
88. (c) ref 5d.
89. (d) Beeler, A. B.; Acquilano, D. E.; Su, Q. B.; Yan, F.; Roth, B. L.; Panek, J. S.; Porco, J. A., Jr. J. Comb. Chem. 2005, 7, 673.
90. For accounts on the methodologies, see: (a) Huang, P.-Q. Recent Advances on the Asymmetric Synthesis of Bioactive 2-Pyrrolidinone-Related Compounds Starting from Enantiomeric Malic Acid. In New Methods for the Asymmetric Synthesis of Nitrogen Heterocycles; Vicario, J. L., Badia, D., Carrillo, L., Eds.; Research Signpost: Kerala, India, 2005; pp 197-222.
91. (b) Huang, P.-Q. Synlett 2006, 1133.
92. (a) Huang, P.-Q.; Wang, S.-L.; Ye, J.-L.; Ruan, Y.-P.; Huang, Y.-Q.; Zheng, H.; Gao, J. Tetrahedron 1998, 54, 12547.
93. (b) For the synthesis of protected AHPPA, see: Huang, P. Q.; Wu, T. J.; Ye, J. L. Chin. J. Chem. 2003, 21, 723.
94. (a) Yamaura, M.; Suzuki, T.; Hashimoto, H.; Yoshimura, J.; Okamoto, T.; Shin, C. Bull. Chem. Soc. Jpn. 1985, 58, 1413.
95. (b) Yoshimura, J.; Yamaura, M.; Suzuki, T.; Hashimoto, H. Chem. Lett. 1983, 1001.
96. (a) Crimmins, M. T.; She, J. Synlett 2004, 1371.
97. (b) Crimmins, M. T.; King, B. W.; Tabet, E. A. J. Am. Chem. Soc. 1997, 119, 7883.
98. Wu, Y. K.; Yang, Y. Q.; Hu, Q. J. Org. Chem. 2004, 69, 3990.
99. Evans, D. A.; Britton, T. C.; Ellman, J. A. Tetrahedron Lett. 1987, 25, 6141.
100. (a) Koch, P.; Nakatani, Y.; Luu, B.; Ourisson, G. Bull. Soc. Chim. Fr. 1983, 11, 11-189.
101. (b) Li, W. R.; Ewing, W. R.; Harris, B. R.; Joullie, M. M. J. Am. Chem. Soc. 1990, 112, 7659.
102. (a) Ḧgberg, T.; Str̈m, P.; Ebner, M.; Rämsby, S. J. Org. Chem. 1987, 52, 2033.
103. (b) Mori, K.; Tominaga, M.; Takigawa, T.; Matsui, M. Synthesis 1973, 790.
104. (c) He, B.-Y.; Wu, T. -J.; Yu, X.-Y.; Huang, P.-Q. Tetrahedron Asymmetry 2003, 14, 2101.
105. For a review on the N-methyl amino acids, see: (a) Aurelio, L.; Brownlee, R. T. C.; Hughes, A. B. Chem. Rev. 2004, 104, 5823.
106. (b) For selected synthesis of N-methyl amino acids, see: Aurelio, L.; Brownlee, R. T. C.; Hughes, A. B. Org. Lett. 2002, 4, 3767.
107. (c) Aurelio, L.; Box, J. S.; Brownlee, R. T. C.; Hughes, A. B.; Sleebs, M. M. J. Org. Chem. 2003, 68, 2652.
108. Yoo, D.; Oh, J. S.; Kim, Y. G. Org. Lett. 2002, 4, 1213.
109. For two examples of stereodivergent synthesis, see: (a) Gierasch, T. M.; Chytil, M. M.; Didiuk, T.; Park, J. Y.; Urban, J. J.; Nolan, S. P.; Verdine, G. L. Org. Lett. 2000, 2, 3999.
110. (b) Misske, A. M.; Hoffmann, H. M. R. Chem.-Eur. J. 2000, 6, 3313.
111. 3SiH mediated ionic hydrognation, see: (a) Kursanov, D. N.; Parnes, Z. N.; Loim, N. M. Synthesis 1974, 633.
112. (b) Nagai, Y. Org. Prep. Proc. Int. 1980, 12, 13.
113. (c) For selective examples, see: Rolf, D.; Gray, G. R. J. Am. Chem. Soc. 1982, 104, 3539.
114. (d) Hart, D. J.; Tsai, Y. M. Tetrahedron Lett. 1981, 22, 1567.
115. (e) Drage, J. S.; Earl, R. A.; Vollhardt, K. P. C. J. Heterocycl. Chem. 1982, 19, 701.
116. Shioiri, T.; Ninomiya, K.; Yamada, S. J. Am. Chem. Soc. 1972, 94, 6203.
117. (a) Umezawa, H.; Aoyagi, T.; Morishima, H.; Matsazuki, M.; Hamada, M.; Takeguchi, T. J. Antibiot. 1972, 25, 251.
118. (b) Umezaua, H.; Morishima, H.; Sawa, T.; Takita, T.; Aoyagi, T.; Takeuchi, T. J. Antibiot. 1974, 27, 267.
119. (a) Rich, D. H. J. Med. Chem. 1985, 28, 263.
120. (b) Rich, D. H. In Proteinase Inhibitors; Barrett, A. J., Salvesen, G., Eds.; Elsevier: New York, 1986; p 179.
121. (a) Mayux, J.-F.; Bousseau, A.; Pauwels, R.; Huest, T.; Henin, Y.; Dereu, N.; Evans, M.; Soler, F.; Poujade, C.; De Clercq, E.; Le Pecq, J.-B. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3564.
122. (b) Sun, I.-C.; Chen, C.-H.; Kashiwada, Y.; Wu, J.-H.; Wang, H.-K.; Lee, K.-H. J. Med. Chem. 2002, 45, 4271.